Invicta Diagnostic IPO — Listing Performance
Invicta Diagnostic IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 1 Dec 2025 |
| Listing date | 8 Dec 2025 |
| Overall subscription | 4.05x |
| Issue price | ₹85 |
| Listing-day close | ₹96.70 (13.76%) |
| Recent market price | ₹68 (-20% vs issue) |
| 52-week range | ₹59.05 – ₹102.75 |
| Identifiers | NSE: INVICTA · ISIN: INE0XJ501010 |
How the listing went
Invicta Diagnostic saw a healthy listing pop, closing day one 13.76% above the issue price, on moderate subscription of 4.05x.
Invicta Diagnostic against every other debut on record
- Rank in 2025: 78 of 215 NSE debuts, on a 13.76% first-day close.
- 60th percentile of 116 SME debuts in 2025 (median 6.52%).
- 11th of 24 debuts in December 2025.
- Subscribed 4.05x: 38th percentile of 165 SME issues with a figure; the 65 subscribed between 1 and 5 times closed day one a median -1.34%.
- Opened 17.65% above issue, then gave up 3.89 points to the close.
- Day-one range ₹95 to ₹105: a 11.76% swing on the issue price.
- Last close ₹68 (11 Sep 2026): 20% below issue, against 13.76% on day one.
- 2% up its 52-week range of ₹59.05 to ₹102.75.
- Priced at the top of the ₹80 to ₹85 band.
- Listed 5 calendar days after close.
- All 601 SME debuts on record: median 14.22%, 79% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources